Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group.

Consensus Female Humans Infant, Newborn Male Oligohydramnios Pregnancy Retrospective Studies Ultrasonography, Prenatal / adverse effects Urethral Diseases Urethral Obstruction / diagnosis Urinary Bladder Urogenital Abnormalities Vesico-Ureteral Reflux

Journal

Nature reviews. Urology
ISSN: 1759-4820
Titre abrégé: Nat Rev Urol
Pays: England
ID NLM: 101500082

Informations de publication

Date de publication:
05 2022
Historique:
accepted: 06 01 2022
pubmed: 10 2 2022
medline: 11 5 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

Fetal lower urinary tract obstruction (LUTO) is associated with high mortality and postnatal morbidity caused by lung hypoplasia and impaired kidney function. Specific diagnostic features that can guide clinical approach and decisions are lacking; thus, the European Reference Network for Rare Kidney Diseases established a work group to develop recommendations regarding the clinical definition, diagnosis and management of prenatally detected LUTO. The work group recommends the use of antero-posterior diameter of renal pelvis as the most reliable parameter for suspecting obstructive uropathies and for suspecting prenatal LUTO in the presence of fetal megacystis. Regarding prenatal and postnatal prognosis of fetuses with LUTO, the risk of fetal and neonatal death depends on the presence of oligohydramnios or anhydramnios before 20 weeks' gestation, whereas the risk of kidney replacement therapy cannot be reliably foreseen before birth. Parents of fetuses with LUTO must be referred to a tertiary obstetric centre with multidisciplinary expertise in prenatal and postnatal management of obstructive uropathies, and vesico-amniotic shunt placement should be offered in selected instances, as it increases perinatal survival of fetuses with LUTO.

Identifiants

DOI: 10.1038/s41585-022-00563-8 PMID: 35136187
pubmed: 35136187
doi: 10.1038/s41585-022-00563-8
pii: 10.1038/s41585-022-00563-8
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-303

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022. Springer Nature Limited.

Références

Anumba, D. O., Scott, J. E., Plant, N. D. & Robson, S. C. Diagnosis and outcome of fetal lower urinary tract obstruction in the northern region of England. Prenat. Diagn. 25, 7–13 (2005).
pubmed: 15662711 doi: 10.1002/pd.1074
Morris, R. K. & Kilby, M. D. Congenital urinary tract obstruction. Best Pract. Res. Clin. Obstet. Gynaecol. 22, 97–122 (2008).
pubmed: 17904905 doi: 10.1016/j.bpobgyn.2007.08.007
Farrugia, M. K. Fetal bladder outlet obstruction: embryopathology, in utero intervention and outcome. J. Pediatr. Urol. 12, 296–303 (2016).
pubmed: 27570093 doi: 10.1016/j.jpurol.2016.05.047
Hobbins, J. C. et al. Antenatal diagnosis of renal anomalies with ultrasound. I. Obstructive uropathy. Am. J. Obstet. Gynecol. 148, 868–877 (1984).
pubmed: 6711628 doi: 10.1016/0002-9378(84)90528-3
Reuss, A., Wladimiroff, J. W., Stewart, P. A. & Scholtmeijer, R. J. Non-invasive management of fetal obstructive uropathy. Lancet 2, 949–951 (1988).
pubmed: 2902391 doi: 10.1016/S0140-6736(88)92609-8
Matsell, D. G., Mok, A. & Tarantal, A. F. Altered primate glomerular development due to in utero urinary tract obstruction. Kidney Int. 61, 1263–1269 (2002).
pubmed: 11918732 doi: 10.1046/j.1523-1755.2002.00274.x
Gough, D. in Essentials of Paediatric Urology (eds Rickwood, A. M. K., Thomas, D. F. M. & Duffy P. G.) (Martin Dunitz Ltd, 2002).
Fontanella, F. et al. Prenatal diagnosis of LUTO: improving diagnostic accuracy. Ultrasound Obstet. Gynecol. 52, 739–743 (2018).
pubmed: 29266464 pmcid: 6587765 doi: 10.1002/uog.18990
Grijseels, E. W. et al. Outcome of pregnancies complicated by oligohydramnios or anhydramnios of renal origin. Prenat. Diagn. 31, 1039–1045 (2011).
pubmed: 21755519 doi: 10.1002/pd.2827
Melo, B. F. et al. Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns. Pediatr. Nephrol. 27, 965–972 (2012).
pubmed: 22402647 doi: 10.1007/s00467-012-2107-y
Capone, V. P., Morello, W., Taroni, F. & Montini, G. Genetics of congenital anomalies of the kidney and urinary tract: the current state of play. Int. J. Mol. Sci. 18, 796 (2017).
pmcid: 5412380 doi: 10.3390/ijms18040796
Heikkila, J., Holmberg, C., Kyllonen, L., Rintala, R. & Taskinen, S. Long-term risk of end stage renal disease in patients with posterior urethral valves. J. Urol. 186, 2392–2396 (2011).
pubmed: 22014822 doi: 10.1016/j.juro.2011.07.109
Ruano, R. et al. Fetal intervention for severe lower urinary tract obstruction: a multicenter case-control study comparing fetal cystoscopy with vesicoamniotic shunting. Ultrasound Obstet. Gynecol. 45, 452–458 (2015).
pubmed: 25157756 doi: 10.1002/uog.14652
Nguyen, H. T. et al. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J. Pediatr. Urol. 10, 982–998 (2014).
pubmed: 25435247 doi: 10.1016/j.jpurol.2014.10.002
Malin, G., Tonks, A. M., Morris, R. K., Gardosi, J. & Kilby, M. D. Congenital lower urinary tract obstruction: a population-based epidemiological study. BJOG 119, 1455–1464 (2012).
pubmed: 22925164 doi: 10.1111/j.1471-0528.2012.03476.x
Chen, Y. et al. A reporting tool for practice guidelines in health care: the RIGHT Statement. Ann. Intern. Med. 166, 128–132 (2017).
pubmed: 27893062 doi: 10.7326/M16-1565
de Villiers, M. R., de Villiers, P. J. & Kent, A. P. The Delphi technique in health sciences education research. Med. Teach. 27, 639–643 (2005).
pubmed: 16332558 doi: 10.1080/13611260500069947
Guyatt, G. H. et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J. Clin. Epidemiol. 64, 395–400 (2011).
pubmed: 21194891 doi: 10.1016/j.jclinepi.2010.09.012
Aulbert, W. & Kemper, M. J. Severe antenatally diagnosed renal disorders: background, prognosis and practical approach. Pediatr. Nephrol. 31, 563–574 (2016).
pubmed: 26081158 doi: 10.1007/s00467-015-3140-4
Ellenbogen, P. H., Scheible, F. W., Talner, L. B. & Leopold, G. R. Sensitivity of gray scale ultrasound in detecting urinary tract obstruction. Am. J. Roentgenol. 130, 731–733 (1978).
doi: 10.2214/ajr.130.4.731
Grignon, A. et al. Urinary tract dilatation in utero: classification and clinical applications. Radiology 160, 645–647 (1986).
pubmed: 3526402 doi: 10.1148/radiology.160.3.3526402
Riccabona, M. et al. Imaging recommendations in paediatric uroradiology: minutes of the ESPR workgroup session on urinary tract infection, fetal hydronephrosis, urinary tract ultrasonography and voiding cystourethrography, Barcelona, Spain, June 2007. Pediatr. Radiol. 38, 138–145 (2008).
pubmed: 18071685 doi: 10.1007/s00247-007-0695-7
Onen, A. An alternative grading system to refine the criteria for severity of hydronephrosis and optimal treatment guidelines in neonates with primary UPJ-type hydronephrosis. J. Pediatr. Urol. 3, 200–205 (2007).
pubmed: 18947735 doi: 10.1016/j.jpurol.2006.08.002
Odibo, A. O. et al. Mild pyelectasis: evaluating the relationship between gestational age and renal pelvic anterior-posterior diameter. Prenat. Diagn. 23, 824–827 (2003).
pubmed: 14558027 doi: 10.1002/pd.709
Chitty, L. S. & Altman, D. G. Charts of fetal size: kidney and renal pelvis measurements. Prenat. Diagn. 23, 891–897 (2003).
pubmed: 14634973 doi: 10.1002/pd.693
Sebire, N. J., Von Kaisenberg, C., Rubio, C., Snijders, R. J. & Nicolaides, K. H. Fetal megacystis at 10–14 weeks of gestation. Ultrasound Obstet. Gynecol. 8, 387–390 (1996).
pubmed: 9014277 doi: 10.1046/j.1469-0705.1997.08060387.x
Fontanella, F. et al. Antenatal workup of early megacystis and selection of candidates for fetal therapy. Fetal Diagn. Ther. 45, 155–161 (2019).
pubmed: 29772579 doi: 10.1159/000488282
Ibirogba, E. R., Haeri, S. & Ruano, R. Fetal lower urinary tract obstruction: what should we tell the prospective parents? Prenat. Diagn. 40, 661–668 (2020).
pubmed: 32065667 doi: 10.1002/pd.5669
Fontanella, F. et al. Fetal megacystis: a lot more than LUTO. Ultrasound Obstet. Gynecol. 53, 779–787 (2019).
pubmed: 30043466 pmcid: 6593717 doi: 10.1002/uog.19182
Fazecas, T. M. et al. Applicability of magnetic resonance imaging in the assessment of fetal urinary tract malformations. Can. Assoc. Radiol. J. 70, 83–95 (2019).
pubmed: 30691568 doi: 10.1016/j.carj.2018.10.006
Shipp, T. D., Bromley, B., Pauker, S., Frigoletto, F. D. Jr. & Benacerraf, B. R. Outcome of singleton pregnancies with severe oligohydramnios in the second and third trimesters. Ultrasound Obstet. Gynecol. 7, 108–113 (1996).
pubmed: 8776235 doi: 10.1046/j.1469-0705.1996.07020108.x
Mercer, L. J. & Brown, L. G. Fetal outcome with oligohydramnios in the second trimester. Obstet. Gynecol. 67, 840–842 (1986).
pubmed: 3703407 doi: 10.1097/00006250-198606000-00019
Barss, V. A., Benacerraf, B. R. & Frigoletto, F. D. Jr. Second trimester oligohydramnios, a predictor of poor fetal outcome. Obstet. Gynecol. 64, 608–610 (1984).
pubmed: 6387555
Moxey-Mims, M. & Raju, T. N. K. Anhydramnios in the setting of renal malformations: the National Institutes of Health Workshop Summary. Obstet. Gynecol. 131, 1069–1079 (2018).
pubmed: 29742659 pmcid: 5970061 doi: 10.1097/AOG.0000000000002637
Underwood, M. A., Gilbert, W. M. & Sherman, M. P. Amniotic fluid: not just fetal urine anymore. J. Perinatol. 25, 341–348 (2005).
pubmed: 15861199 doi: 10.1038/sj.jp.7211290
Morris, R. K., Malin, G. L., Khan, K. S. & Kilby, M. D. Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy. BJOG 116, 1290–1299 (2009).
pubmed: 19438489 doi: 10.1111/j.1471-0528.2009.02194.x
Hindryckx, A. & De Catte, L. Prenatal diagnosis of congenital renal and urinary tract malformations. Facts Views Vis. Obgyn. 3, 165–174 (2011).
pubmed: 24753862 pmcid: 3991456
Elder, J. S., O’Grady, J. P., Ashmead, G., Duckett, J. W. & Philipson, E. Evaluation of fetal renal function: unreliability of fetal urinary electrolytes. J. Urol. 144, 574–578; discussion 593–594 (1990).
pubmed: 2197439 doi: 10.1016/S0022-5347(17)39526-5
Glick, P. L. et al. Management of the fetus with congenital hydronephrosis II: prognostic criteria and selection for treatment. J. Pediatr. Surg. 20, 376–387 (1985).
pubmed: 3900327 doi: 10.1016/S0022-3468(85)80223-2
Morris, R. K., Quinlan-Jones, E., Kilby, M. D. & Khan, K. S. Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction. Prenat. Diagn. 27, 900–911 (2007).
pubmed: 17610312 doi: 10.1002/pd.1810
Berry, S. M. et al. Predictive value of fetal serum beta 2-microglobulin for neonatal renal function. Lancet 345, 1277–1278 (1995).
pubmed: 7746060 doi: 10.1016/S0140-6736(95)90928-1
Spaggiari, E. et al. Fetal obstructive uropathy complicated by urinary ascites: outcome and prognostic value of fetal serum beta-2-microglobulin. Ultrasound Obstet. Gynecol. 41, 185–189 (2013).
pubmed: 23090907 doi: 10.1002/uog.12328
Spaggiari, E. et al. Sequential fetal serum beta2-microglobulin to predict postnatal renal function in bilateral or low urinary tract obstruction. Ultrasound Obstet. Gynecol. 49, 617–622 (2017).
pubmed: 27197901 doi: 10.1002/uog.15968
Luton, D. et al. Foetal serum but not urinary beta2-microglobulin correlates with histological injury to the kidney. Clin. Biochem. 46, 1607–1610 (2013).
pubmed: 23628594 doi: 10.1016/j.clinbiochem.2013.04.017
Dommergues, M. et al. Fetal serum beta2-microglobulin predicts postnatal renal function in bilateral uropathies. Kidney Int. 58, 312–316 (2000).
pubmed: 10886576 doi: 10.1046/j.1523-1755.2000.00167.x
Klein, J. et al. Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci. Transl. Med. 5, 198ra106 (2013).
pubmed: 23946195 doi: 10.1126/scitranslmed.3005807
Buffin-Meyer, B. et al. A single-center study to evaluate the efficacy of a fetal urine peptide signature predicting postnatal renal outcome in fetuses with posterior urethral valves. Pediatr. Nephrol. 35, 469–475 (2020).
pubmed: 31701236 doi: 10.1007/s00467-019-04390-9
Buffin-Meyer, B. et al. Combination of the fetal urinary metabolome and peptidome for the prediction of postnatal renal outcome in fetuses with PUV. J. Proteom. 184, 1–9 (2018).
doi: 10.1016/j.jprot.2018.06.012
Buffin-Meyer, B. et al. The ANTENATAL multicentre study to predict postnatal renal outcome in fetuses with posterior urethral valves: objectives and design. Clin. Kidney J. 13, 371–379 (2020).
pubmed: 32699617 doi: 10.1093/ckj/sfz107
Ruano, R. et al. Fetal lower urinary tract obstruction: proposal for standardized multidisciplinary prenatal management based on disease severity. Ultrasound Obstet. Gynecol. 48, 476–482 (2016).
pubmed: 26690832 doi: 10.1002/uog.15844
Fontanella, F. et al. Antenatal staging of congenital lower urinary tract obstruction. Ultrasound Obstet. Gynecol. 53, 520–524 (2019).
pubmed: 29978555 doi: 10.1002/uog.19172
Morris, R. K. et al. The Percutaneous shunting in Lower Urinary Tract Obstruction (PLUTO) study and randomised controlled trial: evaluation of the effectiveness, cost-effectiveness and acceptability of percutaneous vesicoamniotic shunting for lower urinary tract obstruction. Health Technol. Assess. 17, 1–232 (2013).
pubmed: 24331029 pmcid: 4781393 doi: 10.3310/hta17590
Williams, O., Hutchings, G., Hubinont, C., Debauche, C. & Greenough, A. Pulmonary effects of prolonged oligohydramnios following mid-trimester rupture of the membranes–antenatal and postnatal management. Neonatology 101, 83–90 (2012).
pubmed: 21934333 doi: 10.1159/000329445
Morris, R. K. et al. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet 382, 1496–1506 (2013).
pubmed: 23953766 pmcid: 3898962 doi: 10.1016/S0140-6736(13)60992-7
Morris, R. K., Malin, G. L., Khan, K. S. & Kilby, M. D. Systematic review of the effectiveness of antenatal intervention for the treatment of congenital lower urinary tract obstruction. BJOG 117, 382–390 (2010).
pubmed: 20374578 doi: 10.1111/j.1471-0528.2010.02500.x
Morris, R. K. et al. Outcome in fetal lower urinary tract obstruction: a prospective registry study. Ultrasound Obstet. Gynecol. 46, 424–431 (2015).
pubmed: 25689128 doi: 10.1002/uog.14808
Biard, J. M. et al. Long-term outcomes in children treated by prenatal vesicoamniotic shunting for lower urinary tract obstruction. Obstet. Gynecol. 106, 503–508 (2005).
pubmed: 16135579 doi: 10.1097/01.AOG.0000171117.38929.eb
Nassr, A. A. et al. Effectiveness of vesicoamniotic shunt in fetuses with congenital lower urinary tract obstruction: an updated systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 49, 696–703 (2017).
pubmed: 27270578 doi: 10.1002/uog.15988
Ruano, R., Dunn, T., Braun, M. C., Angelo, J. R. & Safdar, A. Lower urinary tract obstruction: fetal intervention based on prenatal staging. Pediatr. Nephrol. 32, 1871–1878 (2017).
pubmed: 28730376 doi: 10.1007/s00467-017-3593-8
Morris, R. K., Ruano, R. & Kilby, M. D. Effectiveness of fetal cystoscopy as a diagnostic and therapeutic intervention for lower urinary tract obstruction: a systematic review. Ultrasound Obstet. Gynecol. 37, 629–637 (2011).
pubmed: 21374748 doi: 10.1002/uog.8981
Sananes, N. et al. Urological fistulas after fetal cystoscopic laser ablation of posterior urethral valves: surgical technical aspects. Ultrasound Obstet. Gynecol. 45, 183–189 (2015).
pubmed: 24817027 doi: 10.1002/uog.13405
Vinit, N. et al. Fetal cystoscopy and vesicoamniotic shunting in lower urinary tract obstruction: long-term outcome and current technical limitations. Fetal Diagn. Ther. 47, 74–83 (2020).
pubmed: 31401627 doi: 10.1159/000500569
Kilby, M. D. & Morris, R. K. Fetal therapy for the treatment of congenital bladder neck obstruction. Nat. Rev. Urol. 11, 412–419 (2014).
pubmed: 24934451 doi: 10.1038/nrurol.2014.132

Auteurs

Valentina Capone (V)

Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy. valentina.capone@policlinico.mi.it.
ORCID: 0000-0001-9177-3532

Nicola Persico (N)

Fetal Medicine and Surgery Service, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Alfredo Berrettini (A)

Pediatric Urology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Stèphane Decramer (S)

Institut National de la Santé et de la Recherche Médicale (INSERM), U1297, Institut of Cardiovascular and Metabolic Disease, Toulouse, France.
Université Toulouse III Paul-Sabatier, Toulouse, France.
Service de Néphrologie Pédiatrique, Hôpital des Enfants, CHU Toulouse, Toulouse, France.
Centre De Référence des Maladies Rénales Rares du Sud-Ouest (SORARE), Toulouse, France.

Erika Adalgisa De Marco (EA)

Pediatric Urology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Diego De Palma (D)

Nuclear Medicine Unit, "Circolo" Hospital, ASST-settelaghi, Varese, Italy.

Alessandra Familiari (A)

High Risk Pregnancy Unit, Department of Women, Children and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
ORCID: 0000-0002-6353-9383

Wout Feitz (W)

Department of Urology, Division of Paediatric Urology, Radboudumc Amalia Children's Hospital, Nijmegen, Netherlands.
ORCID: 0000-0001-7654-4862

Maria Herthelius (M)

Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
ORCID: 0000-0003-3306-2235

Vytis Kazlauskas (V)

Clinic of Gastroenterology, Nephrourology and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Max Liebau (M)

Department of Pediatrics and Center for Molecular Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
ORCID: 0000-0003-0494-9080

Gianantonio Manzoni (G)

Pediatric Urology Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
ORCID: 0000-0001-9287-2890

Michal Maternik (M)

Department of Pediatrics, Nephrology and Hypertension, Medical University of Gdansk, Gdansk, Poland.
ORCID: 0000-0001-7292-0795

Giovanni Mosiello (G)

Bambino Gesù Pediatric Hospital, Division of Pediatric Urology/Neuro-Urology, Rome, Italy.

Joost Peter Schanstra (JP)

Institut National de la Santé et de la Recherche Médicale (INSERM), U1297, Institut of Cardiovascular and Metabolic Disease, Toulouse, France.
Université Toulouse III Paul-Sabatier, Toulouse, France.
ORCID: 0000-0002-7471-372X

Johan Vande Walle (J)

Paediatric Nephrology and Rheumatology Section, Department of Paediatrics, Ghent University Hospital, Ghent, Belgium.

Elke Wühl (E)

Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany.

Elisa Ylinen (E)

Department of Pediatric Nephrology and Transplantation, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Aleksandra Zurowska (A)

Centre of Rare Diseases, Medical University Gdansk, Gdansk, Poland.

Franz Schaefer (F)

Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.

Giovanni Montini (G)

Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
Giuliana and Bernardo Caprotti Chair of Pediatrics, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
ORCID: 0000-0002-7350-4475

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Personnes › Tranches d'âge › Nourrisson › Nouveau-né › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Maladies urogénitales › Maladies de l'appareil urogénital féminin et complications de la grossesse › Complications de la grossesse › Oligoamnios › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic gynécologique et obstétrique › Diagnostic prénatal › Échographie prénatale › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Maladies de l'urètre › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Maladies de l'urètre › Obstruction urétrale › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Appareil urogénital › Voies urinaires › Vessie urinaire › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Malformations › Malformations urogénitales › Definition, diagnosis and management of fetal...
questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Maladies de la vessie › Reflux vésico-urétéral › Definition, diagnosis and management of fetal...